Timefolio Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2024	Accent Therapeutics	$75.0M Series C	—	Atlas Venture, F-Prime Capital Partners, Leaps by Bayer, Nextech Invest, The Column Group, AbbVie Ventures, Bristol Myers Squibb, Droia Ventures, EcoR1 Capital, Google Ventures, Johnson & Johnson Innovation, Naveen Krishnan, Mirae Asset Venture Investment, The Mark Foundation for Cancer Research

Total Raised

N/A

Valuation

N/A